A Patient-Centric Approach to Drug Development Across the Lifecycle
Time: 8:50 am
day: Day One
Details:
• Incorporating patient perspectives and how to involve patients in gene therapy drug development
• At what stage of the program lifecycle should patients be involved in order to meet their needs and to optimize trial conduct
• How to provide a compelling value proposition for multiple stakeholders
Speakers:
Eileen Sawyer joined uniQure in 2016, where she serves as Vice President and Head of Medical Affairs, leading uniQure’s medical affairs activities across the portfolio with a focus on supporting the hemophilia B gene therapy program. Prior to joining uniQure, she spent 3 years at Alexion Pharmaceuticals where she served as the scientific communications lead for the launch of asfotase alfa (Strensiq),…Read more